HK1142806A1 - Stable solid preparation of egualen sodium - Google Patents
Stable solid preparation of egualen sodiumInfo
- Publication number
- HK1142806A1 HK1142806A1 HK10109226.5A HK10109226A HK1142806A1 HK 1142806 A1 HK1142806 A1 HK 1142806A1 HK 10109226 A HK10109226 A HK 10109226A HK 1142806 A1 HK1142806 A1 HK 1142806A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solid preparation
- stable solid
- egualen sodium
- egualen
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008289702A JP5465867B2 (en) | 2008-11-12 | 2008-11-12 | Stable eguarene sodium solid formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1142806A1 true HK1142806A1 (en) | 2010-12-17 |
Family
ID=42278565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10109226.5A HK1142806A1 (en) | 2008-11-12 | 2010-09-27 | Stable solid preparation of egualen sodium |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5465867B2 (en) |
KR (1) | KR101627860B1 (en) |
CN (1) | CN101732290B (en) |
HK (1) | HK1142806A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861337B (en) * | 2012-03-26 | 2017-08-11 | 北京阜康仁生物制药科技有限公司 | One kind contains solid formulation of egualen sodium |
JP6133702B2 (en) * | 2013-06-18 | 2017-05-24 | 紀州技研工業株式会社 | Ink jet ink, method for producing the same, and method for using the same |
JP6060102B2 (en) * | 2014-03-13 | 2017-01-11 | 紀州技研工業株式会社 | Ink jet ink, method for producing the same, and printing method using the ink jet ink |
JP6426115B2 (en) * | 2016-04-06 | 2018-11-21 | ニプロ株式会社 | Solid pharmaceutical composition containing a calcium blocker |
JP6462625B2 (en) * | 2016-04-06 | 2019-01-30 | ニプロ株式会社 | Tablets containing calcium blockers |
TWI845532B (en) | 2018-07-30 | 2024-06-21 | 日商第一三共股份有限公司 | Solid preparation of medicament comprising stabilizing agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59176247A (en) * | 1983-03-28 | 1984-10-05 | Taiyo Yakuhin Kogyo Kk | Method for preventing decomposition of water-soluble azunole |
JPS6048960A (en) * | 1983-08-24 | 1985-03-16 | Kotobuki Seiyaku Kk | Azulene derivative, its preparation, and antitumor agent containing it as active ingredient |
JPH0648960A (en) * | 1990-02-22 | 1994-02-22 | Glaxo Group Ltd | Medicine |
JP2594395B2 (en) * | 1991-11-27 | 1997-03-26 | 吉富製薬株式会社 | Stabilization method and formulation of sodium azulene sulfonate |
JP3977724B2 (en) * | 2001-11-06 | 2007-09-19 | ロート製薬株式会社 | Pharmaceutical composition |
JP4174300B2 (en) * | 2001-11-13 | 2008-10-29 | 壽製薬株式会社 | Rapidly disintegrating tablet or orally disintegrating tablet containing L-glutamine and sodium azulenesulfonate and method for producing the same |
JP2003160484A (en) * | 2001-11-27 | 2003-06-03 | Kotobuki Seiyaku Kk | Orally administrative preparation composition with mitigated bitterness |
WO2006043336A1 (en) * | 2004-10-20 | 2006-04-27 | Kotobuki Pharmaceutical Co., Ltd. | Therapeutic or preventive composition for gastric mucosa disease |
-
2008
- 2008-11-12 JP JP2008289702A patent/JP5465867B2/en active Active
-
2009
- 2009-11-10 KR KR1020090107814A patent/KR101627860B1/en active IP Right Grant
- 2009-11-12 CN CN2009102260483A patent/CN101732290B/en not_active Expired - Fee Related
-
2010
- 2010-09-27 HK HK10109226.5A patent/HK1142806A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101732290A (en) | 2010-06-16 |
CN101732290B (en) | 2013-08-28 |
JP5465867B2 (en) | 2014-04-09 |
JP2010116337A (en) | 2010-05-27 |
KR20100053449A (en) | 2010-05-20 |
KR101627860B1 (en) | 2016-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201006679B (en) | Orally-disintergrating solid preparation | |
ZA201203615B (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
EP2341910A4 (en) | Immediate release dosage forms of sodium oxybate | |
PL2451435T5 (en) | Sodium thiosulfate-containing pharmaceutical compositions | |
GB0805360D0 (en) | Arabinoxylan oligosaccharide preparation | |
DK3569237T3 (en) | SODIUM NITRITE CONTAINING PHARMACEUTICAL COMPOSITIONS | |
ZA200905134B (en) | Compositions of stable tiacumicins | |
ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
ZA201108375B (en) | Solid preparation | |
PL2133419T3 (en) | Uses of cyanophycin beta-dipeptides | |
IL217112A0 (en) | Regioselective preparation of 2-amino-5- trifluoromethylpyrimidine derivatives | |
ZA201102945B (en) | Biocatalytic preparation of nucleosides | |
HK1160925A1 (en) | Use of athepsin | |
EP2370414A4 (en) | Preparation of capecitabine | |
EP2412366A4 (en) | Solid preparation | |
EP2328873A4 (en) | Preparation of ranolazine | |
HK1142806A1 (en) | Stable solid preparation of egualen sodium | |
PT2137212E (en) | Preparation of mannoprotein solutions | |
IL206577A0 (en) | Formulations of flibanserin | |
SI2303866T1 (en) | Crystalline forms of rabeprazole sodium | |
GB2471253B (en) | Hairdye preparation composition | |
EP2412367A4 (en) | Solid preparation | |
EP2512489A4 (en) | Formulations of acadesine | |
IL209833A0 (en) | Solid dosage formulations of telcagepant potassium | |
GB0922023D0 (en) | Preparation of n-monofluoroalkyl compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171112 |